A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

NCT06739122 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Dulaglutide

Sponsor

Eli Lilly and Company